PFG Investments’s Cardiff Oncology CRDF Stock Holding History

PFG Investments’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.7K	Buy	20,501 +8,000	+64%	+$12.7K	﹤0.01%	1280
2026 Q1	$20.3K	Hold	12,501	–	–	﹤0.01%	1179
2025 Q4	$35.1K	Hold	12,501	–	–	﹤0.01%	1127
2025 Q3	$25.8K	Hold	12,501	–	–	﹤0.01%	1098
2025 Q2	$39.4K	Hold	12,501	–	–	﹤0.01%	1018
2025 Q1	$39.3K	Hold	12,501	–	–	﹤0.01%	981
2024 Q4	$54.3K	Hold	12,501	–	–	﹤0.01%	975
2024 Q3	$33.4K	Hold	12,501	–	–	﹤0.01%	986
2024 Q2	$27.8K	Buy	12,501 +2,500	+25%	+$9.42K	﹤0.01%	914
2024 Q1	$53.4K	Buy	+10,001	New	+$26.6K	﹤0.01%	990

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

PFG Investments's CRDF Position: Q2 2026 in Review

PFG Investments increased its Cardiff Oncology (CRDF) stake by 64% in Q2 2026, buying an estimated $12.7K and bringing the position to 20,501 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

PFG Investments first reported a position in CRDF in Q1 2024 and has held it in 10 quarters since. The position peaked at $54.3K in Q4 2024. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

PFG Investments held 20,501 shares of Cardiff Oncology worth $26.7K as of Q2 2026.
PFG Investments bought 8,000 Cardiff Oncology shares in Q2 2026, an estimated $12.7K.
Cardiff Oncology made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1280 holding.
PFG Investments first reported a position in Cardiff Oncology in Q1 2024 and has held it in 10 quarters since.
PFG Investments's Cardiff Oncology position peaked at $54.3K in Q4 2024.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.